Addison, ILNCT07103083Now EnrollingIRB Ready

Blood Glucose Clinical Trial in Addison, IL

Access cutting-edge blood glucose treatment through this clinical trial at a research site in Addison. Study-provided care at no cost to qualified participants.

Sponsored by Ocean Spray Cranberries, Inc.

Quick Self-Assessment

See if you qualify for this Addison location

Preparing your pre-screening questions…

Expert Care in Addison

Access blood glucose specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related blood glucose treatment provided free

Apply for This Addison Location

Check if you qualify for this blood glucose clinical trial in Addison, IL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Addison

    Convenient for IL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Addison site if eligible
  4. 4Begin participation

About This Blood Glucose Study in Addison

The goal of this clinical trial is to determine postprandial responses to fruit juices.

Sponsor: Ocean Spray Cranberries, Inc.

Who Can Participate

Inclusion Criteria

≥18 to ≤45 years of age at Visit 1.
BMI ≥18.5 and \<30.0 kg/m2 at Visit 1.
Fasting capillary glucose ≤110 mg/dL at Visit 1.
Willing to avoid consuming high-polyphenol containing foods for 48 hours prior to each test visit.
Willing to abstain from alcohol consumption for 24 hours prior to each study visit.
Non-user of tobacco or nicotine products (e.g., cigarette smoking, vaping, chewing tobacco) within 12 months of Visit 1, with no plans to begin use during the study period.
Non-habitual users (i.e., daily or almost daily) of marijuana or hemp products, including Cannabidiol (CBD)/Tetrahydrocannabinol (THC) products, and willing to abstain from use throughout the study period (topical creams/lotions are allowed).
Willing to maintain habitual physical activity level throughout the duration of the study.
Willing to maintain habitual dietary pattern throughout the duration of the study, including stable intake of current vitamins, minerals, supplements and medications not interfering with study outcomes.
Score of 7 to 10 on the Vein Access Scale at Visit 1.
No health conditions that would prevent him/her from fulfilling the study requirements as judged by the Clinical Investigator on the basis of medical history.
Understands the study procedures and signs forms providing informed consent to participate in the study and authorizes the release of relevant protected health information to the Clinical Investigator.

Exclusion Criteria

History or presence of clinically important cardiac, renal, hepatic, endocrine, pulmonary, biliary, pancreatic, gastrointestinal, or neurological disorders that may affect the participant's ability to adhere to the study protocol and/or affect study outcomes, in the judgment of the Clinical Investigator.
Uncontrolled hypertension (systolic blood pressure ≥140 mm Hg or diastolic blood pressure ≥90 mm Hg) as defined by the blood pressure measured at Visit 1 (Section 9.1.1).
Unstable use (initiation or change in dose) within 30 days of Visit 1 of antihypertensive medications.
Unstable use (initiation or change in dose) within 30 days of Visit 1 of thyroid hormone replacement medications.
Use of medications or supplements that may influence carbohydrate metabolism within 30 days of Visit 1.
Extreme dietary habits (e.g., ketogenic, very high protein, very high fiber, vegan, vegetarian) at the discretion of the Clinical Investigator.
Weight loss or gain \>4.5 kg in the 60 days prior to Visit 1.
Currently, or planning to be, on a weight loss regimen during the study.
Use of weight loss medication within 90 days of Visit 1.
History of gastrointestinal surgery for weight reducing purposes.
History of an eating disorder (e.g., anorexia nervosa, bulimia nervosa, or binge eating) diagnosed by a health professional.
Known allergy or sensitivity to any ingredients or potential allergens contained in the study beverages.
History or presence of cancer in the prior 2 years, except for non-melanoma skin cancer.
History of any major trauma or major surgical event within 60 days of Visit 1.
Blood donation \>450 mL within 60 days of Visit 2 or plans to donate blood or plasma during the study period.
Female who is pregnant, planning to be pregnant during the study period, lactating, or is of childbearing potential with unstable use (initiation or change in dose) within 30 days of Visit 1) of sex hormones for contraception.
Recent history of (within 12 months of screening; Visit 1) or strong potential for alcohol or substance abuse. Alcohol abuse is defined as \>14 drinks per week (1 drink = 12 oz beer, 5 oz wine, or 1½ oz distilled spirits).
Exposed to any non-registered drug product within 30 days prior to Visit 1.
Any condition the Clinical Investigator believes would interfere with the participant's ability to provide informed consent or comply with the study protocol, which might confound the interpretation of the study results or put the person at undue risk.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Addison?

Yes, this clinical trial (NCT07103083) has an active research site in Addison, IL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Blood Glucose Treatment Options in Addison, IL

If you're searching for blood glucose treatment options in Addison, IL, this clinical trial (NCT07103083) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Addison research site is actively enrolling participants for this clinical trial. You'll receive care from experienced blood glucose specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all blood glucose clinical trials near you to find additional studies recruiting in your area.

More Ulcerative Colitis Trials in Addison, IL

See all ulcerative colitis clinical trials recruiting in Addison — not just this study.

Browse Ulcerative Colitis Trials in Addison →

Browse More Trials by Condition

Ulcerative Colitis TrialsAll Conditions →

Ready to Join in Addison?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Addison, IL